PLoS ONE (Jan 2019)

Quantitative magnetic resonance imaging indicates brain tissue alterations in patients after liver transplantation.

  • Lukas Laurids Goede,
  • Henning Pflugrad,
  • Birte Schmitz,
  • Heinrich Lanfermann,
  • Anita Blanka Tryc,
  • Hannelore Barg-Hock,
  • Jürgen Klempnauer,
  • Karin Weissenborn,
  • Xiao-Qi Ding

DOI
https://doi.org/10.1371/journal.pone.0222934
Journal volume & issue
Vol. 14, no. 9
p. e0222934

Abstract

Read online

PurposeTo investigate cerebral microstructural alterations in patients treated with calcineurin inhibitors (CNI) after orthotopic liver transplantation (OLT) using quantitative magnetic resonance imaging (qMRI) and a cross-sectional study design.MethodsCerebral qMRI was performed in 85 patients in a median 10 years after OLT compared to 31 healthy controls. Patients were treated with different dosages of CNI or with a CNI-free immunosuppression (CNI-free: n = 19; CNI-low: n = 36; CNI-standard: n = 30). T2-, T2*- and T2'- relaxation times, as well as apparent diffusion coefficient (ADC) and fractional anisotropy (FA) were measured in brain gray and white matter by using the regions of interest method.ResultsIn comparison to controls, patients revealed significantly increased T2, T2*, T2', ADC and reduced FA, predominantly in the frontal white matter, indicating microstructural brain alterations represented by increased free water (increased T2), reduced neuronal metabolism (increased T2') and a lower degree of spatial organization of the nervous fibers (reduced FA). CNI-low and CNI-free patients showed more alterations than CNI-standard patients. Analysis of their history revealed impairment of kidney function while under standard CNI dose suggesting that these patients may be more vulnerable to toxic CNI side-effects.ConclusionOur findings suggest that the individual sensitivity to toxic side effects should be considered when choosing an appropriate immunosuppressive regimen in patients after liver transplantation.